Ra Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch RARX and buy or sell other stocks, ETFs, and their options commission-free!

About RARX

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. 

CEO
Doug Treco, PhD
CEODoug Treco, PhD
Employees
Employees
Headquarters
Smyrna, Georgia
HeadquartersSmyrna, Georgia
Founded
2008
Founded2008
Employees
Employees

RARX Key Statistics

Market cap
2.27B
Market cap2.27B
Price-Earnings ratio
-20.91
Price-Earnings ratio-20.91
Dividend yield
Dividend yield
Average volume
2.38M
Average volume2.38M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$48.02
52 Week high$48.02
52 Week low
$19.64
52 Week low$19.64

Stock Snapshot

The current Ra Pharmaceuticals(RARX) stock price is $48.00, with a market capitalization of 2.27B. The stock trades at a price-to-earnings (P/E) ratio of -20.91.

On 2026-04-03, Ra Pharmaceuticals(RARX) stock opened at —, reached a high of —, and a low of —.

Ra Pharmaceuticals(RARX) shares are trading with a volume of 0, against a daily average of 2.38M.

In the last year, Ra Pharmaceuticals(RARX) shares hit a 52-week high of $48.02 and a 52-week low of $19.64.

In the last year, Ra Pharmaceuticals(RARX) shares hit a 52-week high of $48.02 and a 52-week low of $19.64.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.